Shawn Iadonato - Dec 16, 2022 Form 4 Insider Report for KINETA, INC./DE (KA)

Role
Chief Executive Officer, Director
Signature
/s/ Pauline Kenny, as Attorney-in-Fact
Stock symbol
KA
Transactions as of
Dec 16, 2022
Transactions value $
$100,000
Form type
4
Date filed
12/20/2022, 07:57 PM
Next filing
Mar 21, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KA Common Stock Award +622K 622K Dec 16, 2022 Direct F1
transaction KA Common Stock Award +30.1K +4.85% 652K Dec 16, 2022 Direct F2, F3
transaction KA Common Stock Award +8.6K +1.32% 660K Dec 16, 2022 Direct F4, F5
transaction KA Common Stock Award $100K +8.66K +1.31% $11.55* 669K Dec 16, 2022 Direct F6
transaction KA Common Stock Award +8.55K 8.55K Dec 16, 2022 By IRA F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KA Stock Option (Right to Buy) Award +47K 47K Dec 16, 2022 Common Stock 47K $23.25 Direct F7, F8
transaction KA Stock Option (Right to Buy) Award +3.64K 3.64K Dec 16, 2022 Common Stock 3.64K $29.73 Direct F9, F10
transaction KA Stock Option (Right to Buy) Award +15.6K 15.6K Dec 16, 2022 Common Stock 15.6K $25.58 Direct F7, F11
transaction KA Stock Option (Right to Buy) Award +23.9K 23.9K Dec 16, 2022 Common Stock 23.9K $27.03 Direct F9, F12
transaction KA Stock Option (Right to Buy) Award +26.1K 26.1K Dec 16, 2022 Common Stock 26.1K $28.48 Direct F13, F14
transaction KA Stock Option (Right to Buy) Award +124K 124K Dec 16, 2022 Common Stock 124K $12.11 Direct F7, F15
transaction KA Warrants (Right to Buy) Award +1.38K 1.38K Dec 16, 2022 Common Stock 1.38K $0.14 Direct F16, F17
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Received in connection with the Issuer's merger (the "Merger") with Kineta, Inc. ("Legacy Kineta") in accordance with the terms of the Agreement and Plan of Merger dated as of June 5, 2022, as amended on December 5, 2022 (the "Merger Agreement"), by and among the Issuer (f/k/a Yumanity Therapeutics, Inc.), Yacht Merger Sub, Inc. and Legacy Kineta. Pursuant to the terms of the Merger Agreement, each outstanding share of Legacy Kineta common stock was entitled to receive 0.0688 shares of Common Stock. The Merger closed on December 16, 2022.
F2 Represents shares of Common Stock underlying time-based restricted stock unit awards ("RSUs"). The RSUs will vest in full on June 14, 2023, subject to the continuing employment of the Reporting Person on such vesting date.
F3 Received in connection with the Merger in exchange for 437,910 shares of common stock underlying Legacy Kineta RSUs.
F4 Represents shares of Common Stock underlying a time-based RSU. The RSU will vest in full on March 16, 2023, subject to the continuing employment of the Reporting Person on such vesting date.
F5 Received in connection with the Merger in exchange for 125,000 shares of common stock underlying a Legacy Kineta RSU.
F6 Represents shares of Common Stock acquired by the Reporting Person immediately following the Merger in a private placement pursuant to a Securities Purchase Agreement dated as of June 5, 2022 and as amended on October 24, 2022 and December 5, 2022. The issuance of the shares to the Reporting Person was approved by the Company's board of directors in the manner contemplated by Rule 16b-3 under the Securities Exchange Act of 1934, as amended.
F7 The stock option is fully vested and exercisable.
F8 Received in connection with the Merger in exchange for options to acquire 682,728 shares of Legacy Kineta common stock for $1.60 per share.
F9 The stock option vested as to 1/3 of the total number of shares on May 31, 2022, and an additional 1/3 of the total number of shares will vest on each yearly anniversary thereafter, until such time as the stock option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.
F10 Received in connection with the Merger in exchange for options to acquire 52,910 shares of Legacy Kineta common stock for $2.046 per share.
F11 Received in connection with the Merger in exchange for options to acquire 227,272 shares of Legacy Kineta common stock for $1.76 per share.
F12 Received in connection with the Merger in exchange for options to acquire 347,090 shares of Legacy Kineta common stock for $1.86 per share.
F13 The stock option vested as to 1/3 of the total number of shares on May 27, 2021, an additional 1/3 of the total number of shares vested on May 27, 2022, and the remaining 1/3 of the total number of shares will vest on May 27, 2023, subject to the continuing employment of the Reporting Person on each vesting date.
F14 Received in connection with the Merger in exchange for options to acquire 380,000 shares of Legacy Kineta common stock for $1.96 per share.
F15 Received in connection with the Merger in exchange for options to acquire 1,800,000 shares of Legacy Kineta common stock for $0.8333 per share.
F16 The warrants are immediately exercisable in full.
F17 Received in connection with the Merger in exchange for warrants to acquire 20,101 shares of Legacy Kineta common stock for $0.01 per share.